Christian Angermayer

Christian Angermayer

Formal First Name
4/26/1978 - present

Christian Angermayer is the Founder of Apeiron Investment Group, a merchant banking business based in Sliema, Malta. He is recognized as one of the most active investors in fintech companies in Europe, particularly on cryptocurrencies and blockchain-related business models. His current interests include cryptocurrencies and blockchain-related business models, longevity and anti-aging technologies, aerospace technologies, and new drugs for mental wellbeing and enhancement.


  • With over 20 years in the industry, Angermayer has created, co-founded, and invested in numerous successful companies across a broad section of sectors.
  • He has raised over $2 billion for his portfolio companies.
  • He has been involved in more than 50 successful IPO- and M&A-transactions either as an entrepreneur, investor, or advisor.
  • With ATAI Life Sciences, he seeks to develop solutions for the more than 300 million people who suffer from various mental health issues like depression, anxiety, addiction, and PTSD by bringing formerly vilified drugs like psychedelics.
  • With Rejuveron and Cambrian, he is developing drugs and technologies which have the potential to significantly prolong the human life span and ultimately defeat death.
  • He serves as a member and advisor to several global economic and political think-tanks, institutes and councils.
  • UK Newspaper Sunday Times ranks him among the 1.000 richest people living in the United Kingdom, with an estimated net worth of approximately $700 million.


  • Angermayer has produced at least 21 feature films, including critically acclaimed movies like Filth, Aspern Papers and Hector And The Search For Happiness.
  • He is the largest shareholder of DEAG, one of the largest live entertainment companies in Europe, producing over 4,500 shows per year.
  • He has a unique art collection that centers around psychedelics and entheogens.
  • He has served as Chairman of Film House Germany AG since 2011.